Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
98%
High-risk Human Papillomavirus (HR-HPV)
78%
Head-and-neck Cancer
38%
Mesenchymal Stromal Cells
36%
Radiation Effects
36%
Meta-analysis
36%
Systematic Meta-analysis
36%
Population-based Study
29%
Hyposalivation
23%
Danish Population
22%
Xerostomia
20%
Salivary Gland Diseases
16%
Denmark
16%
Overall Survival
16%
HPV16
15%
Human Papillomavirus Genotypes
15%
Human Papillomavirus Testing
15%
Cancer Patients
14%
HPV Positive
14%
National Cohort Study
14%
Randomized Placebo-controlled Trial
14%
Stem Cell Therapy
14%
Epidemiological Trends
14%
Mesenchymal Stem Cell Therapy
14%
Cancer Mortality
12%
Adipokinetic Hormone
12%
Placebo
12%
Hazard Ratio
12%
Human Papillomavirus Prevalence
11%
Salivary Flow Rate
11%
HPV Genotyping
10%
Allogeneic
10%
Radiation-induced Xerostomia
9%
Long-term Safety
9%
Tonsil
9%
Confidence Interval
9%
Cancer of Unknown Primary
9%
Head-and-neck
8%
HPV Negative
8%
Long-term Efficacy
8%
High Prevalence
8%
Mortality Risk
8%
Single Center
8%
Prognostic Marker
8%
Prognostic Impact
7%
Tonsillar Squamous Cell Carcinoma
7%
Base of Tongue
7%
Recurrence-free Survival
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Bilateral Tonsillar Carcinoma
7%
Medicine and Dentistry
Wart Virus
100%
Oropharynx Squamous Cell Carcinoma
81%
Systematic Review
66%
Oropharyngeal Cancer
38%
Meta-Analysis
38%
Xerostomia
33%
Head and Neck Cancer
30%
Hyposalivation
30%
Adipose Tissue
26%
Stromal Cell
22%
Salivation
21%
Overall Survival
20%
Placebo
20%
Prevalence
19%
Salivary Gland
15%
Human Papillomavirus Type 16
15%
Stem Cell Therapy
14%
Cell Therapy
14%
P16
13%
Mesenchymal Stem Cell
12%
Hazard Ratio
10%
Squamous Cell Carcinoma
10%
Neck
9%
Tonsil
9%
Radiation Therapy
9%
Neoplasm
9%
Cancer of Unknown Primary Origin
9%
Base
7%
Recurrent Disease
7%
Recurrence Free Survival
7%
Second Cancer
7%
Focal Epithelium Hyperplasia
7%
Tonsil Carcinoma
7%
Lymphocyte
7%
Adjuvant Therapy
7%
Robot-Assisted Surgery
7%
Chromatin Immunoprecipitation
7%
Epidemic
7%
Neutrophil
7%
Diagnostic Accuracy
7%
Patient Characteristics
7%
Bone Marrow Derived Mesenchymal Stem Cell
7%
Network Meta-Analysis
7%
Time to Treatment
7%
COVID-19
7%
Phase II Trials
7%
Tongue
7%
Oropharynx Carcinoma
7%
Malignant Neoplasm
6%
Clinical Trial
6%